Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,800
Closed -$3.14M 499
2025
Q4
$3.14M Sell
29,800
-20,800
-41% -$1.95M 0.07% 244
2025
Q3
$4.25M Buy
50,600
+10,700
+27% +$881K 0.1% 195
2025
Q2
$3.16M Buy
39,900
+37,300
+1,435% +$2.96M 0.08% 239
2025
Q1
$233K Sell
2,600
-1,500
-37% -$140K 0.01% 744
2024
Q4
$408K Sell
4,100
-300
-7% -$30.9K 0.01% 632
2024
Q3
$500K Buy
+4,400
New +$523K 0.01% 652
2023
Q3
Sell
-49,800
Closed -$5.75M 1181
2023
Q2
$5.75M Buy
49,800
+35,100
+239% +$3.99M 0.09% 121
2023
Q1
$1.56M Sell
14,700
-9,900
-40% -$1.07M 0.03% 352
2022
Q4
$2.73M Buy
24,600
+20,600
+515% +$2.11M 0.06% 188
2022
Q3
$345K Buy
4,000
+200
+5% +$17.9K 0.01% 898
2022
Q2
$346K Sell
3,800
-5,200
-58% -$461K 0.01% 706
2022
Q1
$738K Sell
9,000
-300
-3% -$23.7K 0.03% 427
2021
Q4
$713K Sell
9,300
-29,000
-76% -$2.31M 0.02% 451
2021
Q3
$2.88M Buy
+38,300
New +$2.91M 0.09% 162
2020
Q3
Sell
-10,166
Closed -$750K 705
2020
Q2
$750K Sell
10,166
-12,366
-55% -$931K 0.05% 247
2020
Q1
$1.65M Buy
22,532
+11,842
+111% +$931K 0.2% 72
2019
Q4
$927K Buy
+10,690
New +$878K 0.08% 183

Other funds holding MRK

Maven Securities's MRK Position: Q2 2025 in Review

Maven Securities sold out of Merck (MRK) in Q2 2025, closing a stake of 2,785 shares — an estimated $221K sold.

Maven Securities first reported a position in MRK in Q2 2020 and held it in 12 quarters. The position peaked at $3.36M in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Maven Securities reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Maven Securities sold 2,785 Merck shares in Q2 2025, an estimated $221K.
  • Maven Securities first reported a position in Merck in Q2 2020 and held it in 12 quarters.
  • Maven Securities's Merck position peaked at $3.36M in Q1 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.